AI Terminal
Karolinska Development
Major Shareholding Notification • Oct 14, 2021
3168_iss_2021-10-14_46a7d305-1ba3-490b-bc08-1c5750b6f9b6.pdf
Major Shareholding Notification
Open in ViewerOpens in native device viewer
Issuer Karolinska Development AB
Holder
Sino Biopharmaceutical Limited
Instrument
| Instrument | Shares (Series B) SE0002190926 |
|---|---|
| Before the transaction | |
| Shares | 75,727,285 |
| Voting rights | 75,727,285 |
| Transaction | |
| Reason for major shareholding notification Change of the group related parties | |
| Date | 04/10/2021 |
| Limit for number of shares | 30 % |
| Limit for number of votes | 30 % |
| After the transaction | |
| Quantity | |
| Shares | 75,727,285 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 75,727,285 |
| Percentage | |
| Directly held shares | 43.10882 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 40.02641 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 40.02641 % | 75,727,285 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 40.02641 % | 75,727,285 |
Chain of controlling companies
| Voting rights % Voting rights Company | ||
|---|---|---|
| 75,727,285 40.02641 | Invox Pharma Limited | |
| 0 | 0 | Sino Biopharmaceutical Limited |
| 0 | 0 | Chia Tai Resources Limited |
| Group total |
holdings | |
| Voting rights | 75,727,285 |
Percentage of voting rights 40.02641
Notes (other relevant informations according to law)
This notification is submitted by Sino Biopharmaceutical Limited on behalf of its subsidiaries, Chia Tai Resources Limited and Invox Pharma Limited, in accordance with Chapter 4, Section 6 of the Act on Trading in Financial Instruments (Sw. lag (1991:980) om handel med finansiella instrument). The notification reflects an intragroup reorganisation whereby all shares in Karolinska Development AB previously held by Sino Biopharmaceutical Limited and Chia Tai Resources Limited have been transferred to Invox Pharma Limited. Prior to the reorganisation, Sino Biopharmaceutical Limited directly and indirectly held 75 727 285 shares and voting rights in Karolinska Development AB, equivalent to 43,10882 percent of all shares and 40,02641 percent of all the voting rights in Karolinska Development AB, according to the following chain of controlling companies: Company Number of voting rights Percentage of voting rights Sino Biopharmaceutical Limited 4 853 141 2,56517 Chia Tai Resources Limited 70 874 144 37,46124 After the reorganisation, Sino Biopharmaceutical Limited indirectly holds 75 727 285 shares and voting rights in Karolinska Development AB, equivalent to 43,10882 percent of all shares and 40,02641 percent of all the voting rights in Karolinska Development AB, according to the following chain of controlling companies: Company Number of voting rights Percentage of voting rights Sino Biopharmaceutical Limited 0 0 Chia Tai Resources Limited 0 0 Invox Pharma Limited 75 727 285 40,02641
Published
14/10/2021 13:46
Contact
Name Tyron Hussey
Phone 07541691673 Email [email protected]
| CLOSE | |
|---|---|
| ------- | ------- |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25